Q4 2025 Holdings
Filed 2026-02-17 | 21 holdings | $295.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $70.5M | 1,746,264 | 23.9% |
| CG Oncology Inc(CGON) | COM | 156944100 | $47.0M | 1,131,501 | 15.9% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $33.9M | 1,448,420 | 11.5% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $26.9M | 2,144,844 | 9.1% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $24.6M | 4,131,299 | 8.3% |
| Candel Therapeutics Inc(CADL) | COM | 137404109 | $14.6M | 2,580,517 | 4.9% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $12.9M | 1,573,023 | 4.4% |
| Verastem Inc(VSTM) | COM | 92337C203 | $11.3M | 1,469,153 | 3.8% |
| Bicara Therapeutics(BCAX) | COM | 055477103 | $10.8M | 643,382 | 3.7% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $9.3M | 1,752,115 | 3.2% |
| Onkure Therapeutics Inc(OKUR) | CLASS A COM | 68277Q105 | $8.2M | 2,839,674 | 2.8% |
| Cardif Oncology Inc(CRDF) | COM | 14147L108 | $5.5M | 1,962,084 | 1.9% |
| Athira Pharma Inc.(LONA) | COMMON STOCK | 04746L203 | $3.8M | 501,739 | 1.3% |
| Jasper Therapeutics(JSPR) | COM | 471871202 | $3.3M | 1,786,492 | 1.1% |
| Aura Biosciences Inc(AURA) | COM | 05153U107 | $3.2M | 595,744 | 1.1% |
| Whitehawk Therapeutics Inc(WHWK) | COM | 00032Q104 | $2.8M | 1,139,363 | 0.9% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $2.8M | 4,835,111 | 0.9% |
| Q32 BIO Inc.(QTTB) | COM | 746964105 | $1.6M | 493,425 | 0.6% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $1.1M | 273,349 | 0.4% |
| Acrivon Therapeutics Inc(ACRV) | COMMON STOCK | 004890109 | $976.6K | 405,237 | 0.3% |
| Vyne Therapeutics Inc(VYNE) | COM | 92941V308 | $827 | 1,425 | 0.0% |